Search
Inclusion of New Risk Factors Can Improve Prediction of Invasive Breast Cancer
UCSF researchers update Breast Cancer Surveillance Consortium model to account for BMI and other familial risk factors.Focused Ultrasound Technology May Overcome Barrier to Brain Tumor Treatments
The blood-brain barrier protects the brain from many viruses, bacteria, and other harmful small molecules that could be circulating throughout the body. However, this same barrier prevents many cancer therapies from reaching brain tumors.UCSF Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell therapy for multiple myeloma, the second most common malignancy among blood cancers.Prominent Orthopaedic Surgeon and Researcher to Lead UCSF Orthopaedics Program
C. Benjamin Ma, MD, a highly regarded orthopaedic surgeon and advanced imaging researcher, has been appointed as chair of the UCSF Department of Orthopaedic Surgery. Ma assumed his new role on January 1, 2024.Improving Prediction of Advanced Breast Cancer Among Women of Different Races and Ethnicities
While regular screenings may decrease the chance of diagnosis of advanced breast cancer in some women and lead to a 20% reduction in breast cancer mortality, other women will be diagnosed with advanced breast cancer despite screening at regular intervals.UCSF Health’s Eric Small, MD, Elected ASCO President for 2025-2026 Term
The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025.Why Do Some Long Covid Patients Continue to Have Difficulty Exercising?
While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.Millions of Long-Term Smokers Have Lung Disease that Defies Diagnosis
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria – including the most common of those, chronic obstructive pulmonary disease (COPD)...Aggressive Blood Pressure Control May Prevent Common Heart Condition
Heart conduction disorders can often lead to serious or fatal complications including complete heart block or heart failure.UCSF Among First in U.S. to Receive New Surgery Designation from the American College of Surgeons
UC San Francisco Medical Center (UCSF) is among just four hospitals in the U.S. to be verified as part of the American College of Surgeons (ACS) Vascular Verification Program (Vascular-VP)...Can Artificial Intelligence Reduce Invasive Testing and Improve Cardiac Diagnostics?
Coronary heart disease is the leading cause of adult death worldwide.UCSF Surgical Oncologists Providing New Treatment Options for Patients with Metastatic Gastrointestinal Cancers
UCSF Health’s surgical oncology team is a Bay Area leader in an innovative chemotherapy infusion pump used to treat patients with widely metastatic colorectal and bile duct cancers that have spread to the liver and are no longer considered operable.Interventional Cardiology Program
The UCSF Interventional Cardiology Program offers the latest minimally invasive catheter-based procedures to diagnose and treat the full spectrum of cardiovascular conditions.Novel Tricuspid and Mitral Valve Procedures Improve Patients' Quality of Life
UC San Francisco interventional cardiologists and interventional echocardiographers recently performed two novel minimally invasive cardiac procedures for the first time in the health system.UCSF Health Joins Registry to Improve Cardiogenic Shock Treatment
UC San Francisco’s Heart and Vascular Center has been recognized by The American Heart Association (AHA) for its participation in a new Cardiogenic Shock Registry.Prenatal Enzyme Replacement Therapy for Lysosomal Storage Diseases
Pregnant patients with a diagnosed fetal lysosomal storage disease may have the opportunity to receive a promising treatment that could improve their babies’ health after birth.Breast Cancer Risk Calculator Can Assess Risk of Advanced Breast Cancer
Upcoming Conference to Focus on Breast Density and Prediction of Advanced and Interval Breast Cancer RiskUCSF and I-SPY 2 Breast Cancer Researchers Develop Newly Redefined Breast Cancer Response Subtypes
Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients.Novel Metabolic Imaging Method Detects Prostate Cancer Aggressiveness
UCSF investigators have shown that adding an emerging metabolic imaging technique to MR–transrectal ultrasound fusion prostate biopsies makes it possible to detect the extent and aggressiveness of prostate cancer more accurately than ever.Cardiology Transfer Guide
Cardiology Transfer GuideUCSF Researchers Develop Prediction Model of Aortic Aneurysm
Ascending thoracic aortic disease is an important cause of sudden death in the U.S., yet most aortic aneurysms are identified incidentally.UCSF Launches Initiative to Address Disparities in Pulse Oximetry Performance
This project seeks to improve accuracy for patients with darker skin pigmentation.Artificial Intelligence and Wearable Sensors Put the Gait Lab in the Patient’s Pocket
UCSF orthopaedic surgeon Stefano Bini, MD, in collaboration with Google’s Advanced Technologies and Products (ATAP) division, is developing technology that will revolutionize how providers measure joint function and quantify joint disease. This groundbreaking approach uses cutting-edge machine-learning algorithms and data collected from inexpensive, wearable inertial sensors to accurately replicate gait lab outputs for a fraction of the cost of traditional methods, and in any context.UCSF Neurologist to Receive Prestigious Scientific Award
Stephen L. Hauser, MD, Professor of Neurology and Director of the UCSF Weill Institute for Neurosciences, has been chosen by the American Brain Foundation (ABF) to receive its second annual Scientific Breakthrough Award. Hauser is being honored for his career-long commitment to advancing the understanding of the genetic basis, immune mechanisms and treatment of multiple sclerosis (MS).